EligibleTrials

Medication: clinical trials recruiting now

3
Recruiting trials
12
Conditions studied
0
US states with sites
3
Countries

FDA drug label

FDA-approved
Yes. Medication appears in the FDA drug-label database. Marketed as OGEE CLEARGANICS TARGETED BLEMISH TREATMENT.

FDA-approved use

Uses For the treatment of acne.

FDA recalls / enforcement

Reason (FDA)ClassificationStatusInitiated
cGMP deviations — Pharmadel, LLC Class II (FDA: may cause temporary or reversible harm) Terminated 2025-04-15
Labeling: Label Error on Declared Strength: The incorrect label on the back of the product packaging. — RB Health (US) LLC Class III (FDA: unlikely to cause harm) Terminated 2023-08-29
CGMP Deviations: Manufactured without following Current Good Manufacturing Practises. — Equibal Inc Class II (FDA: may cause temporary or reversible harm) Terminated 2024-06-26

FDA label via openFDA

Phase breakdown

Not applicable 3

Conditions being studied

ConditionTrials
Atrial Fibrillation2
Arrhythmia Atrial1
Atrial Fibrillation (AF)1
Atrial Functional Mitral Regurgitation1
Catheter Ablation1
Diabetes1
Dyslipidemia1
Heart Failure1
Hypertension1
Obesity1
Pacemaker1
Pre Diabetes1

Recruiting trials involving Medication

Common questions

Is Medication FDA-approved?

Yes, marketed as OGEE CLEARGANICS TARGETED BLEMISH TREATMENT.

How many recruiting trials involve Medication?

3 recruiting trials across 12 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.